James L Wade

  • 9108 Citations
1984 …2020

Research output per year

If you made any changes in Pure these will be visible here soon.

Personal profile

Certifications and Licenses

Internal Medicine
Medical Oncology

Training Experience

1981Residency, Univ. of Illinois Hospital
1984Fellowship, University of Chicago Hospitals

Education/Academic qualification

MD, University of Illinois at Chicago

… → 1978

Fingerprint Dive into the research topics where James L Wade is active. These topic labels come from the works of this person. Together they form a unique fingerprint.

  • 6 Similar Profiles

Network Recent external collaboration on country level. Dive into details by clicking on the dots.

Research Output

  • 9108 Citations
  • 76 Article
  • 11 Review article

A prospective study to validate the functional assessment of cancer therapy (FACT) for epidermal growth factor receptor inhibitor (EGFRI)-induced dermatologic toxicities FACT-EGFRI 18 questionnaire: SWOG S1013

Wong, S. F., Unger, J. M., Wade, J. L., Wagner, L. I., Lacouture, M. E., Humphries, K. C., Moseley, A., Arnold, K., Velasco, M. R., Floyd, J. D., Esparaz, B. T., Barzi, A., Lenz, H. J., Koczywas, M., Dakhil, S., Burton, G. V., Fisch, M. J., Henry, N. L., Hershman, D. L. & Moinpour, C. M., Dec 1 2020, In : Journal of Patient-Reported Outcomes. 4, 1, 54.

Research output: Contribution to journalArticle

Open Access
  • A randomized phase 2 study of temsirolimus and cetuximab versus temsirolimus alone in recurrent/metastatic, cetuximab-resistant head and neck cancer: The MAESTRO study

    Seiwert, T. Y., Kochanny, S., Wood, K., Worden, F. P., Adkins, D., Wade, J. L., Sleckman, B. G., Anderson, D., Brisson, R. J., Karrison, T., Stadler, W. M. & Vokes, E. E., Jul 15 2020, In : Cancer. 126, 14, p. 3237-3243 7 p.

    Research output: Contribution to journalArticle

  • 1 Scopus citations

    Clinical assessment of 5-fluorouracil/leucovorin, nab-paclitaxel, and irinotecan (folfirabrax) in untreated patients with gastrointestinal cancer using UGT1A1 genotype–guided dosing

    Joshi, S. S., Catenacci, D. V. T., Karrison, T. G., Peterson, J. D., Zalupski, M. M., Sehdev, A., Wade, J., Sadiq, A., Picozzi, V. J., Amico, A., Marsh, R., Kozloff, M. F., Polite, B. N., Kindler, H. L. & Sharma, M. R., Jan 1 2020, In : Clinical Cancer Research. 26, 1, p. 18-24 7 p.

    Research output: Contribution to journalArticle

  • Utilization of clinical pathways can reduce drug spend within the oncology care model

    Hertler, A., Chau, S., Khetarpal, R., Bassin, E., Dang, J., Koppel, D., Damarla, V. & Wade, J., May 1 2020, In : JCO Oncology Practice. 16, 5, p. E456-E463

    Research output: Contribution to journalArticle

    Open Access
  • 1 Scopus citations

    Association between body mass index and response to duloxetine for aromatase inhibitor-associated musculoskeletal symptoms in SWOG S1202

    Henry, N. L., Unger, J. M., Till, C., Schott, A. F., Crew, K. D., Lew, D. L., Fisch, M. J., Moinpour, C. M., Wade, J. L. & Hershman, D. L., Jun 15 2019, In : Cancer. 125, 12, p. 2123-2129 7 p.

    Research output: Contribution to journalArticle

  • 1 Scopus citations